233 related articles for article (PubMed ID: 8912895)
1. Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7.
Bartus RT; Elliott PJ; Dean RL; Hayward NJ; Nagle TL; Huff MR; Snodgrass PA; Blunt DG
Exp Neurol; 1996 Nov; 142(1):14-28. PubMed ID: 8912895
[TBL] [Abstract][Full Text] [Related]
2. Unlocking the blood-brain barrier: a role for RMP-7 in brain tumor therapy.
Elliott PJ; Hayward NJ; Huff MR; Nagle TL; Black KL; Bartus RT
Exp Neurol; 1996 Oct; 141(2):214-24. PubMed ID: 8812155
[TBL] [Abstract][Full Text] [Related]
3. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.
Matsukado K; Inamura T; Nakano S; Fukui M; Bartus RT; Black KL
Neurosurgery; 1996 Jul; 39(1):125-33; discussion 133-4. PubMed ID: 8805148
[TBL] [Abstract][Full Text] [Related]
4. Intravenous RMP-7 selectively increases uptake of carboplatin into rat brain tumors.
Elliott PJ; Hayward NJ; Dean RL; Blunt DG; Bartus RT
Cancer Res; 1996 Sep; 56(17):3998-4005. PubMed ID: 8752170
[TBL] [Abstract][Full Text] [Related]
5. Cereport (RMP-7) increases carboplatin levels in brain tumors after pretreatment with dexamethasone.
Dean RL; Emerich DF; Hasler BP; Bartus RT
Neuro Oncol; 1999 Oct; 1(4):268-74. PubMed ID: 11550318
[TBL] [Abstract][Full Text] [Related]
6. Evidence that Cereport's ability to increase permeability of rat gliomas is dependent upon extent of tumor growth: implications for treating newly emerging tumor colonies.
Bartus RT; Snodgrass P; Dean RL; Kordower JH; Emerich DF
Exp Neurol; 2000 Jan; 161(1):234-44. PubMed ID: 10683290
[TBL] [Abstract][Full Text] [Related]
7. The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation.
Emerich DF; Dean RL; Osborn C; Bartus RT
Clin Pharmacokinet; 2001; 40(2):105-23. PubMed ID: 11286321
[TBL] [Abstract][Full Text] [Related]
8. Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors.
Inamura T; Nomura T; Bartus RT; Black KL
J Neurosurg; 1994 Nov; 81(5):752-8. PubMed ID: 7931623
[TBL] [Abstract][Full Text] [Related]
9. Dissociation of blood-brain barrier permeability and the hypotensive effects of the bradykinin B2 agonist, RMP-7.
Elliott PJ; Hayward NJ; Dean RL; Bartus RT
Immunopharmacology; 1996 Jun; 33(1-3):205-8. PubMed ID: 8856151
[No Abstract] [Full Text] [Related]
10. Enhanced delivery of carboplatin into brain tumours with intravenous Cereport (RMP-7): dramatic differences and insight gained from dosing parameters.
Emerich DF; Snodgrass P; Dean R; Agostino M; Hasler B; Pink M; Xiong H; Kim BS; Bartus RT
Br J Cancer; 1999 Jun; 80(7):964-70. PubMed ID: 10362103
[TBL] [Abstract][Full Text] [Related]
11. Steroids decrease uptake of carboplatin in rat gliomas--uptake improved by intracarotid infusion of bradykinin analog, RMP-7.
Matsukado K; Nakano S; Bartus RT; Black KL
J Neurooncol; 1997 Sep; 34(2):131-8. PubMed ID: 9210059
[TBL] [Abstract][Full Text] [Related]
12. Intravenous cereport (RMP-7) enhances delivery of hydrophilic chemotherapeutics and increases survival in rats with metastatic tumors in the brain.
Emerich DF; Dean RL; Marsh J; Pink M; Lafreniere D; Snodgrass P; Bartus RT
Pharm Res; 2000 Oct; 17(10):1212-9. PubMed ID: 11145226
[TBL] [Abstract][Full Text] [Related]
13. Intravenous cereport (RMP-7) modifies topographic uptake profile of carboplatin within rat glioma and brain surrounding tumor, elevates platinum levels, and enhances survival.
Bartus RT; Snodgrass P; Marsh J; Agostino M; Perkins A; Emerich DF
J Pharmacol Exp Ther; 2000 Jun; 293(3):903-11. PubMed ID: 10869391
[TBL] [Abstract][Full Text] [Related]
14. Intra-arterial administration of carboplatin and the blood brain barrier permeabilizing agent, RMP-7: a toxicologic evaluation in swine.
Riley MG; Kim NN; Watson VE; Gobin YP; LeBel CP; Black KL; Bartus RT
J Neurooncol; 1998 Jan; 36(2):167-78. PubMed ID: 9525816
[TBL] [Abstract][Full Text] [Related]
15. Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI study.
Côté J; Savard M; Bovenzi V; Dubuc C; Tremblay L; Tsanaclis AM; Fortin D; Lepage M; Gobeil F
Neuropeptides; 2010 Apr; 44(2):177-85. PubMed ID: 20080302
[TBL] [Abstract][Full Text] [Related]
16. Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: evidence for a sensitive, auto-regulated, receptor-mediated system.
Bartus RT; Elliott P; Hayward N; Dean R; McEwen EL; Fisher SK
Immunopharmacology; 1996 Jun; 33(1-3):270-8. PubMed ID: 8856161
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin modulation of tumor vasculature: I. Activation of B2 receptors increases delivery of chemotherapeutic agents into solid peripheral tumors, enhancing their efficacy.
Emerich DF; Snodgrass P; Dean RL; Lafreniere D; Agostino M; Wiens T; Xiong H; Hasler B; Marsh J; Pink M; Kim BS; Bartus RT
J Pharmacol Exp Ther; 2001 Feb; 296(2):623-31. PubMed ID: 11160651
[TBL] [Abstract][Full Text] [Related]
18. Repeated, short-term ischemia augments bradykinin-mediated opening of the blood-tumor barrier in rats with RG2 glioma.
Liu Y; Hashizume K; Samoto K; Sugita M; Ningaraj N; Asotra K; Black KL
Neurol Res; 2001 Sep; 23(6):631-40. PubMed ID: 11547933
[TBL] [Abstract][Full Text] [Related]
19. Intracarotid infusion of bradykinin selectively increases blood-tumor permeability in 9L and C6 brain tumors.
Nomura T; Inamura T; Black KL
Brain Res; 1994 Oct; 659(1-2):62-6. PubMed ID: 7529648
[TBL] [Abstract][Full Text] [Related]
20. Steroids decrease uptake of carboplatin in rat gliomas--uptake improved by intracarotid infusion of bradykinin analog, RMP-7.
Matsukado K; Nakano S; Bartus RT; Black KL
Acta Neurochir Suppl; 1997; 70():159-61. PubMed ID: 9416308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]